tm logo

Monitor this mark

View On USPTO

SUPERNUS PHARMACEUTICALS
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 31 Oct 2024

Last Applicant/ Owned by

Supernus Pharmaceuticals, Inc.

9715 Key West Avenue

ROCKVILLE

MD

20850

Serial Number

87657063 filed on 24th Oct 2017

Registration Number

5464617 registered on 08th May 2018

in the Principal Register

Correspondent Address

Mark D Simpson

Mark D Simpson Saul Ewing LLP

Centre Square West, 38th Floor

PHILADELPHIA, PA 19102

United States

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

SUPERNUS PHARMACEUTICALS

Pharmaceuticals preparations for the treatment of central nervous system disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceuticals preparations for the treatment of central nervous system disorders

First Use Date in General

31st Dec 2007

First Use Date in Commerce

31st Dec 2007

Mark Details

Serial Number

No 87657063

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 356969.00046

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.20 -

Circles within a circle

26.01.21 -

Circles that are totally or partially shaded

26.01.30 -

Four Circles

Legal History

Show more

Status DateAction Taken
31st Oct 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
31st Oct 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
30th Oct 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08th May 2024TEAS SECTION 8 & 15 RECEIVED
08th May 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08th May 2018REGISTERED-PRINCIPAL REGISTER
20th Feb 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20th Feb 2018PUBLISHED FOR OPPOSITION
31st Jan 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05th Jan 2018ASSIGNED TO LIE